NCT00061087View on ClinicalTrials.gov

Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
ADHDOpioid-Related DisordersCocaine Dependence
Interventions
DRUG

Methylphenidate

Methylphenidate 80mg/day

DRUG

Bupropion

Bupropion 400mg/day

OTHER

Placebo

Placebo

Trial Locations (1)

10032

Research Foundation for Mental Hygiene, Inc., New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00061087 - Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 | Biotech Hunter | Biotech Hunter